CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study results

Data ReadoutNeutral
AI Analysis

Summary

Summit and Akeso presented latest study results for their PD-1/VEGF combination drug candidate, aiming to address doubts about the therapeutic approach.

Importance:5/10
Sentiment:
0.00
immunotherapyPD-1 inhibitorVEGFclinical trialstudy results
Related Companies

Read the original article

Published by yahoo_finance on September 14, 2026 4:41 PM

Read Original